Novartis is thriving with double-digit growth, driven by key drugs in oncology, cardiology, immunology, and neurology. See ...

For the billions of people who still live in poverty, the path to prosperity may look very different than it has since World ...

Heading into this year, most U.S. farmers were hoping to break even or maybe record a small profit. But Trump's tariffs have created new anxiety.